-

Annual Shareholder’s Meeting of Groupe Berkem: Availability of Preparatory Documents and Participation and Voting Procedures

  • Annual Shareholder’s Meeting to be held on June 22, 2023 at 4:00 pm CEST, at the Mercure Paris Gare Montparnasse Hotel, 40 rue du Commandant René Mouchotte, Paris

BLANQUEFORT, France--(BUSINESS WIRE)--Regulatory News:

Groupe Berkem, a leading player in bio-based chemicals (ISIN code: FR00140069V2 - Ticker: ALKEM), announced that the Annual Shareholder’s Meeting of the Company will be held on Thursday, June 22, 2023 at 4:00 pm CEST, at the Mercure Paris Gare Montparnasse Hotel, 40 rue du Commandant René Mouchotte, 75 014, Paris.

All documents for the Shareholder’s Meeting are available on the Company's website, in the Shareholders' Meeting section.

To exercise their vote, shareholders may, in accordance with the procedures described in the notice published in the BALO on May 17, 2023 and reminded in the convening notice published in the BALO today:

  • attend the Annual Shareholder’s Meeting in person;
  • vote by mail;
  • give proxy to the Chairman of the Meeting; or
  • be represented by any other person of their choice.

ABOUT GROUPE BERKEM

Founded in 1993 by Olivier Fahy, Chairman and Chief Executive Officer, Groupe Berkem is a leading force in the bio-based chemicals market. Its mission is to advance the environmental transition of companies producing the chemicals used in everyday life (Construction & Materials, Health, Beauty & Nutrition, Hygiene & Protection, and Industry). By harnessing its expertise in both plant extraction and innovative formulations, Groupe Berkem has developed bio-based boosters—unique high-quality bio-based solutions augmenting the performance of synthetic molecules. Groupe Berkem achieved revenue of €51.8 million in 2022. The Group has almost 200 employees working at its head office (Blanquefort, Gironde) and 3 production facilities in Gardonne (Dordogne), La Teste-de-Buch (Gironde), and Chartres (Eure-et-Loir).

Groupe Berkem has been listed on Euronext Growth Paris since December 2021 (ISIN code: FR00140069V2 - ALKEM).
www.groupeberkem.com

Contacts

Groupe Berkem
Olivier Fahy, Chairman and CEO
Anthony Labrugnas, Chief Financial Officer
Phone: +33 (0)5 64 31 06 60
investisseurs@berkem.com

NewCap
Investor Relations
Mathilde Bohin / Nicolas Fossiez
Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu

NewCap
Media Relations
Nicolas Merigeau / Antoine Pacquier
Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu

Groupe Berkem

BOURSE:ALKEM

Release Versions

Contacts

Groupe Berkem
Olivier Fahy, Chairman and CEO
Anthony Labrugnas, Chief Financial Officer
Phone: +33 (0)5 64 31 06 60
investisseurs@berkem.com

NewCap
Investor Relations
Mathilde Bohin / Nicolas Fossiez
Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu

NewCap
Media Relations
Nicolas Merigeau / Antoine Pacquier
Phone: +33 (0)1 44 71 94 94
berkem@newcap.eu

More News From Groupe Berkem

Result of the Simplified Tender Offer on Groupe Berkem Shares

BLANQUEFORT, France--(BUSINESS WIRE)--Regulatory News: Groupe Berkem (ISIN code: FR00140069V2 - mnemonic: ALKEM) (the “Company”), a leading player in plant-based chemistry, announces that the Autorité des marchés financiers (AMF) has today published the final result of the simplified tender offer on Groupe Berkem shares (the “Offer”) initiated by Kenerzeo (the “Offeror”). At the close of the Offer, opened from December 9, 2024, to December 20, 2024 included, Kenerzeo individually holds a total...

Groupe Berkem Launches RECELLCL'IN®, Its New Active Ingredient Dedicated to the Cosmetic Market

BLANQUEFORT, France--(BUSINESS WIRE)--Regulatory News: Groupe Berkem (Paris:ALKEM), a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), today announced the launch of RECELLCL'IN®, a new active ingredient for the beauty industry. Marlène De Matos, Groupe Berkem's Active Ingredient Development & Innovation R&D Manager, stated: “For this product launch, we drew the power of polyphenols from the heart of passiflora, to turn a traditionally used plant into an i...

Groupe Berkem Announces Its Revenue of €40.4 Million as of September 30, 2024

BLANQUEFORT, France--(BUSINESS WIRE)--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), announces its revenue as of September 30, 2024, and provides an update on its recent activity. 2024 THIRD-QUARTER REVENUE As of September 30, 2024, Groupe Berkem’s revenue for the first nine months of 2024 reached €40.4 million, against €39.9 million over the same period in 2023, i.e. an increase of +1.2%. Repartition of revenue per business ar...
Back to Newsroom